Company profile: CSI Laboratories
1.1 - Company Overview
Company description
- Provider of diagnostic laboratory services for pathologists, including cytogenetics and molecular genetics (FISH), immunohistochemistry, NGS-based profiles for solid tumors and hematologic malignancies, liquid biopsy, hereditary cancer testing, and comprehensive hematological evaluations with clinical review, morphology, and flow cytometry.
Products and services
- Lumera Heme NGS Profile: An NGS-based diagnostic profile evaluating over 670 genes for hematological malignancies, enabling extensive genomic assessment tailored to blood cancers
- Lumera Xpanded Profile: A pathology-integrated, comprehensive test combining next-generation sequencing with molecular pathology review to analyze DNA and RNA variants in solid tumors for thorough variant assessment
- Lumera NGS Profile: A multi-gene assay using next-generation sequencing to analyze over 500 genes for DNA and RNA variants in solid tumors, supporting broad variant detection
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to CSI Laboratories
PhenoPath
HQ: United States
Website
- Description: Provider of physician-owned, Seattle-based national pathology reference laboratory services specializing in immunohistochemistry, PD-L1 interpretation, flow cytometry, FISH, PCR, cytogenetics, and special stains to assist in the diagnosis and prognosis of cancer patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PhenoPath company profile →
National Rad
HQ: United States
Website
- Description: Provider of subspecialty diagnostic radiology and consulting services, offering detailed interpretations for musculoskeletal, neuro, and body radiology; primary reads, over-reads, and expert/second opinions; teleradiology and IT integration/support; consulting and accreditation; diagnosis-specific MRI protocols and safety reviews; and image optimization for low-field, in-office extremity MRI systems.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full National Rad company profile →
Gruppo Veneto Diagnostica e Riabilitazione
HQ: Italy
Website
- Description: Provider of diagnostic imaging, physical medicine and rehabilitation, offering manual lymphatic drainage for lymphedema and lipedema; rehabilitation for lymphatic and venous disorders with personalized plans; a health and wellness gym for functional recovery, motor maintenance and chronic condition programs; GVDR LAB biomechanical and metabolic evaluations for clinical and sports use; and metabolic and gentle fitness with personalized exercise and dietary guidance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gruppo Veneto Diagnostica e Riabilitazione company profile →
Biostat
HQ: United States
Website
- Description: Provider of comprehensive diagnostic testing that reduces the time it takes to confirm a diagnosis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biostat company profile →
Korva Labs
HQ: United States
Website
- Description: Provider of accredited, CLIA-certified mass spectrometry laboratory services specializing in clinical, sports anti-doping, analytical, and research work; inspected and fully licensed by the California Department of Public Health and the Drug Enforcement Agency (DEA).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Korva Labs company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for CSI Laboratories
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to CSI Laboratories
2.2 - Growth funds investing in similar companies to CSI Laboratories
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for CSI Laboratories
4.2 - Public trading comparable groups for CSI Laboratories
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →